OSMOPREP: payments to doctors
Payments that named OSMOPREP as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $489K
- Providers
- 2
- Transactions
- 20
- Average per transaction
- $24,437
The per-transaction average — $24,437 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2 providers the average total is $244,372, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $488,726 | 100.0% |
| Orapharma, A Division Of Bausch Health US, LLC | $17 | 0.0% |